Optimization of Fc-mediated effector functions of monoclonal antibodies

被引:99
|
作者
Strohl, William R. [1 ]
机构
[1] Centocor R&D Inc, Antibody Drug Discovery, Radnor, PA 19087 USA
关键词
DEPENDENT CELLULAR CYTOTOXICITY; HUMAN IGG1; IN-VIVO; ANTIINFLAMMATORY ACTIVITY; IMMUNOGLOBULIN-G; STRUCTURAL-CHARACTERIZATION; THERAPEUTIC ANTIBODIES; ENGINEERED ANTIBODIES; ENHANCED BINDING; GAMMA-RIIIA;
D O I
10.1016/j.copbio.2009.10.011
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The engineering of therapeutic and clinical candidate monoclonal antibodies and Fc fusion proteins is becoming more sophisticated at generating molecules that are better suited to the pharmacological activity required of them. There are at least 14 marketed and clinical candidate antibodies and Fc fusion proteins in which the Fc has been modified, either via changes in amino acid sequence or in glycoforms. Recent research and development activities in Fc engineering to generate 'fit-for-purpose' antibodies and Fc fusion proteins are reviewed.
引用
收藏
页码:685 / 691
页数:7
相关论文
共 50 条
  • [1] Enhancing Fc-mediated effector functions of monoclonal antibodies: The example of HexaBodies
    van Der Horst, Hilma J.
    Mutis, Tuna
    [J]. IMMUNOLOGICAL REVIEWS, 2024,
  • [2] Enzymatic manipulation of antibody Fc-mediated effector functions
    Sundberg, Eric
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2016, 71 : 67 - 67
  • [3] A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies
    Bailey, Mark J.
    Broecker, Felix
    Leon, Paul E.
    Tan, Gene S.
    [J]. JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2018, (132):
  • [4] Improved Fc-mediated effector functions by an anti-CTLA-4 multivalent Fc agent
    Rutitzky, Laura
    Ortiz, Daniel F.
    Lansing, Jonathan C.
    Brown, Julia
    Paquette, Joseph
    Garofalo, Kevin
    D'Alessandro, Josephine
    Bhatnagar, Naveen
    Hains, Maurice
    Gupta, Abhinav
    Lee, Stan
    Zouaoui, Radouane
    Wang, Jason
    Schaeck, John
    Marchese, Salvatore
    Meccariello, Robin
    Washburn, Nathaniel
    Holte, Kimberly
    Bosques, Carlos J.
    Manning, Anthony M.
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [5] Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact
    Leon, Paul E.
    He, Wenqian
    Mullarkey, Caitlin E.
    Bailey, Mark J.
    Miller, Matthew S.
    Krammer, Florian
    Palese, Peter
    Tan, Gene S.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (40) : E5944 - E5951
  • [6] HIV-1 Vpu restricts Fc-mediated effector functions in vivo
    Prevost, Jeremie
    Anand, Sai Priya
    Rajashekar, Jyothi Krishnaswamy
    Zhu, Li
    Richard, Jonathan
    Goyette, Guillaume
    Medjahed, Halima
    Gendron-Lepage, Gabrielle
    Chen, Hung-Ching
    Chen, Yaozong
    Horwitz, Joshua A.
    Grunst, Michael W.
    Zolla-Pazner, Susan
    Haynes, Barton F.
    Burton, Dennis R.
    Flavell, Richard A.
    Kirchhoff, Frank
    Hahn, Beatrice H.
    Smith, Amos B.
    Pazgier, Marzena
    Nussenzweig, Michel C.
    Kumar, Priti
    Finzi, Andres
    [J]. CELL REPORTS, 2022, 41 (06):
  • [7] Genetic Variants of Fcγ (GM Allotypes) and the Fc-Mediated Effector Functions in HIV-1 Controllers
    Pandey, Janardan P.
    [J]. JOURNAL OF VIROLOGY, 2014, 88 (12) : 7117 - 7117
  • [8] Fc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and Disease
    van Erp, Elisabeth A.
    Luytjes, Willem
    Ferwerda, Gerben
    van Kasteren, Puck B.
    [J]. FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [9] Fc-Mediated Functions of Porcine IgG Subclasses
    Paudyal, Basudev
    Mwangi, William
    Rijal, Pramila
    Schwartz, John C.
    Noble, Alistair
    Shaw, Andrew
    Sealy, Joshua E.
    Bonnet-Di Placido, Marie
    Graham, Simon P.
    Townsend, Alain
    Hammond, John A.
    Tchilian, Elma
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [10] Importance of Fc-mediated functions of anti-HIV-1 broadly neutralizing antibodies
    Matthew S. Parsons
    Amy W. Chung
    Stephen J. Kent
    [J]. Retrovirology, 15